IRIS
SCARPA, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 11.646
NA - Nord America 9.476
EU - Europa 7.382
SA - Sud America 1.399
AF - Africa 272
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 8
Totale 30.201
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.066
SG - Singapore 5.440
RU - Federazione Russa 3.470
VN - Vietnam 2.118
CN - Cina 1.981
BR - Brasile 1.137
IT - Italia 1.104
HK - Hong Kong 1.076
FR - Francia 543
UA - Ucraina 440
DE - Germania 401
FI - Finlandia 371
NL - Olanda 246
IE - Irlanda 238
CA - Canada 233
JP - Giappone 193
GB - Regno Unito 190
IN - India 167
AR - Argentina 111
BD - Bangladesh 111
SE - Svezia 104
MX - Messico 102
ZA - Sudafrica 76
IQ - Iraq 67
KR - Corea 61
PL - Polonia 58
ES - Italia 56
PH - Filippine 53
TH - Thailandia 53
CI - Costa d'Avorio 45
EC - Ecuador 41
TW - Taiwan 37
PK - Pakistan 35
TR - Turchia 35
ID - Indonesia 29
MA - Marocco 25
VE - Venezuela 24
EG - Egitto 22
UZ - Uzbekistan 22
CO - Colombia 21
AT - Austria 20
PY - Paraguay 20
JO - Giordania 19
CL - Cile 17
SA - Arabia Saudita 16
CH - Svizzera 15
KE - Kenya 15
LB - Libano 15
TN - Tunisia 15
AE - Emirati Arabi Uniti 14
AU - Australia 14
MY - Malesia 14
JM - Giamaica 13
LT - Lituania 13
PE - Perù 13
AZ - Azerbaigian 12
BE - Belgio 11
CZ - Repubblica Ceca 11
PT - Portogallo 11
BG - Bulgaria 10
CR - Costa Rica 10
DZ - Algeria 10
GR - Grecia 10
IL - Israele 10
ET - Etiopia 9
IR - Iran 9
SN - Senegal 9
TT - Trinidad e Tobago 8
AL - Albania 7
NP - Nepal 7
OM - Oman 7
RO - Romania 7
BH - Bahrain 6
DK - Danimarca 6
IS - Islanda 6
KZ - Kazakistan 6
MN - Mongolia 6
SV - El Salvador 6
UY - Uruguay 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
BZ - Belize 5
GA - Gabon 5
HN - Honduras 5
HU - Ungheria 5
DO - Repubblica Dominicana 4
GF - Guiana Francese 4
GH - Ghana 4
GT - Guatemala 4
HR - Croazia 4
KG - Kirghizistan 4
LU - Lussemburgo 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PA - Panama 4
SY - Repubblica araba siriana 4
BB - Barbados 3
CG - Congo 3
CW - ???statistics.table.value.countryCode.CW??? 3
CY - Cipro 3
Totale 30.121
Salva come PNG Salva come JPEG
Città #
Singapore 2.445
San Jose 1.415
Hong Kong 1.040
Moscow 860
Ashburn 707
Ho Chi Minh City 616
Chandler 517
Hanoi 457
Santa Clara 457
Jacksonville 443
Beijing 441
The Dalles 434
Lauterbourg 329
Millbury 295
Princeton 292
Boston 291
Los Angeles 254
Naples 231
Hefei 205
Nanjing 194
Amsterdam 186
Buffalo 176
Tokyo 174
Napoli 134
Wilmington 127
New York 119
Des Moines 115
Redondo Beach 112
Ottawa 110
São Paulo 103
Da Nang 91
Haiphong 81
Munich 77
Dallas 72
Orem 67
Houston 62
Nanchang 62
Seattle 59
Lawrence 57
Milan 55
Frankfurt am Main 54
Mexico City 51
Biên Hòa 44
Shenyang 44
Brooklyn 43
Helsinki 43
Hải Dương 43
Tianjin 43
Hebei 42
Jiaxing 42
Norwalk 42
Denver 41
Montreal 41
Warsaw 41
Rome 40
Turku 38
Atlanta 37
Nuremberg 36
Chennai 35
Chicago 35
Belo Horizonte 33
Dublin 33
Falkenstein 33
Boardman 32
Council Bluffs 32
Johannesburg 31
Seoul 31
Toronto 31
Changsha 30
Phoenix 27
Baghdad 25
Can Tho 25
San Francisco 24
Shanghai 24
Brasília 23
Dhaka 23
Poplar 22
Salerno 22
Stockholm 22
Mumbai 21
Porto Alegre 21
Cava de' Tirreni 20
Falls Church 20
Ann Arbor 19
Amman 18
London 18
Manchester 18
Washington 18
Bangkok 17
Bến Tre 17
Guayaquil 17
New Delhi 17
Tashkent 17
Woodbridge 17
Ankara 16
Curitiba 16
Dong Ket 16
Guangzhou 16
Hangzhou 16
Rio de Janeiro 16
Totale 15.691
Salva come PNG Salva come JPEG
Nome #
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 223
A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease 198
Analysis of rheumatoid- vs psoriatic arthritis synovial fluid reveals differential macrophage (CCR2) and T helper subsets (STAT3/4 and FOXP3) activation 163
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: A randomised, controlled, crossover study 160
Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs. 148
ASPETTI CLINICI E GENETICI DELLA ARTRITE DELLA COLITE ULCEROSA CRONICA 147
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 145
RILIEVO DI UN'INCIDENZA ESTREMAMENTE BASSA DI FRATTURE DEL FEMORE PROSSIMALE DA OSTEOPOROSI NELLA POPOLAZIONE DELL'ISOLA DI ISCHIA 144
Fragility Fractures in Patients with Psoriatic Arthritis 143
Artrite psoriasica resistente a più DMARDs. 139
Il methotrexate nella terapia dell'artrite periferica in corso di rettocolite ulcerosa 139
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 138
The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. 138
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study 138
Nuovi farmaci nell'artrite psoriasica. Etanercept. 135
Psoriatic arthritis and psoriasis: differential diagnosis 135
Acromegalic axial arthropathy: a clinical case-control study 134
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer. 132
malattie autoimmuni in gravidanza 131
A rare enthesopathy in psoriatic oligoarthritis. 126
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 126
Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. 125
Malattie autoimmuni in gravidanza 125
METODICHE STRUMENTALI PER LA VALUTAZIONE DELL'OSTEOPOROSI NELLE MALATTIE REUMATICHE 124
Small molecule therapy for managing moderate to severe psoriatic arthritis 124
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies 123
Psoriasis, Psoriatic Arthritis, or Psoriatic Disease? 122
Dactylitis in enteropathic spondyloarthritis 122
Magnetic resonance imaging of nail unit in psoriatic arthritis 122
contributo di ricerca 121
Ulcerative colitis in psoriatic arthritis: preliminary report 121
Psoriasi, artrite psoriasica o malattia psoriasica. 120
Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept 120
Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis 120
Long-term safety of anti-TNF-? in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. 119
Clinical presentation of Psoriatic Arthritis. 118
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study 118
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis” 118
Association between Leeds Dactylitis Index and ultrasonographic features: a multicentre study on psoriatic hand dactylitis 118
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 118
Exploring the dual role of Mangifera indica L. in regulating immune response and pain persistence in inflammatory bowel disease 117
Is the involvement of distal interphalangeal joint of psoriatic pateints related to nail psoriasis? 117
Hepatic steatosis, carotid plaques and achieving MDA in psoriaticarthritis patients starting TNF-alpha blockers treatment: a prospective study. 117
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection 117
Corrigendum to "Measuring psoriatic disease in clinical practice. An expert opinion position paper" [Autoimmun. Rev. 14/10 (2015) p.864-874] 117
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients 117
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy 116
Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. 116
Screening and Monitoring of Latent Tubercular Infection in Patients Taking Tumor Necrosis Factor-α Blockers for Psoriatic Arthritis 116
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome 116
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis 116
Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms 115
Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients. 115
Juvenile rheumatoid arthritis, Crohn's disease and Turner's syndrome: a novel association. 115
Interplay between environmental factors, articular involvement, and HLA-B27 in patients with psoriatic arthritis. 115
Consecutive occurrence of rhinoconjunctivitis, seronegative spondyloarthritis and pyoderma gangrenosum in a patient with ulcerative colitis. 115
Interleukin-17A (IL-17A): A silent amplifier of COVID-19 115
LA COMPLICANZA ARTICOLARE DELLA MALATTIA CELIACA. STUDIO SU 62 CASI: RISULTATI PRELIMINARI 114
Accelerated bone turnover identifies hemiplegic patients at higher risk of demineralization 114
Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort 114
Clinical and genetic aspects of psoriatic arthritis "sine psoriasis" 113
May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)? 112
contributo di ricerca 112
Thalassemic Trait Prevalence in Patients Affected by Psoriatic Arthritis in Anti-TNF Treatment 112
Infliximab in the treatment of seronegative spondyloarthropathies 111
Allergy and mucosal eosinophil infiltrate in ulcerative colitis 111
Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months. 111
Epidemiologia ed aspetti socioeconomici dell’osteoporosi. 111
Improving telemedicine and in-person management of rheumatic and autoimmune diseases,during and after COVID-19 pandemic outbreak. Definite need for more Rheumatologists. Response to: 'Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?' by Akpabio et al 111
contributo di ricerca 110
JAK/STAT/PKC? molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis 110
Simple clinical indicators for early psoriatic arthritis detection 110
Prevention of rheumatoid arthritis using a familial predictive medicine approach 109
Determinants of bone mineral density in immobilization: a study on hemiplegic patients. 109
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 109
contributo di ricerca 109
Skin and joint involvement in rats with trinitrobenzenesulfonic acid induced colitis 109
Treatment options: NSAIDs and DMARDs 109
Effectiveness of steroid injection for hand psoriatic dactylitis: results from a multicentre prospective observational study 109
Managing Moderate-to-Severe Psoriasis in the Elderly. 108
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 108
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 108
Progressive systemic sclerosis and S-adenosylmethionine. 107
Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients 107
contributo di ricerca 107
Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months 106
Clinical presentation of psoriatic arthritis. 106
Prevention of tuberculosis in patients taking tumor necrosis factor-alpha blockers. 106
Osteoporosis and psoriatic arthritis. 106
Efficacy and tolerability of an injectable formulation of tiaprofenic acid in patients with acute back and neck pain. 105
Diffuse idiopathic skeletal hyperostosis (DISH): a retrospective analysis. 105
Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical study. 105
Ultrasonographic and clinical assessment of peripheral enthesitis in patients with psoriatic arthritis, psoriasis, and fibromyalgia syndrome: The ULISSE study 105
Reversibility of joint thickening in acromegalic patients: an ultrasonography study. 104
OSTEOPOROSI ED ARTRITE PSORIASICA 104
RILIEVI CLINICI SULL'IMPIEGO DI UN TRATTAMENTO ANTIARTROSICO DI BASE 104
Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study 102
Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis 102
The definition and measurement of axial psoriatic arthritis 102
Efficacy of tocilizumab in a patient with refractory psoriatic arthritis 101
Totale 11.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021134 0 0 0 0 0 0 0 0 0 0 108 26
2021/20221.549 13 9 2 16 6 47 7 73 237 65 309 765
2022/20231.494 356 84 35 85 155 163 6 127 186 173 97 27
2023/20241.218 43 182 167 71 61 95 37 99 13 24 278 148
2024/20258.347 537 664 30 138 149 409 816 518 810 855 2.662 759
2025/202614.871 1.790 1.095 1.504 1.308 2.497 681 1.678 1.096 2.067 858 297 0
Totale 30.648